Cheryl Gault insider trades

Open-market stock purchases and sales by Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, Inc, from SEC Form 4 filings since Dec 9, 2021.

Recent trades

DateStockTradeValue
Mar 30, 2026RAPP Rapport Therapeutics, IncSold$201K
Mar 30, 2026RAPP Rapport Therapeutics, IncSold$81.1K
Mar 5, 2026RAPP Rapport Therapeutics, IncSold$58.3K
Feb 2, 2026RAPP Rapport Therapeutics, IncBought (not open market)—
Nov 26, 2025RAPP Rapport Therapeutics, IncSold$150K
Nov 26, 2025RAPP Rapport Therapeutics, IncBought (not open market)—

Companies traded

  • RAPP Rapport Therapeutics, Inc: 5 sales, last Mar 30, 2026
  • CYCN Cyclerion Therapeutics, Inc: other filings, last Jan 20, 2022

Get free alerts when Cheryl Gault files a new trade →